News and Events
- February 02, 2017
TCGA study identifies four subtypes of rare nervous system cancers
Researchers with The Cancer Genome Atlas Network determined that pheochromocytomas (PCC) and paragangliomas (PGL) can be classified into four distinct subtypes and also found several novel alterations never before seen in these rare cancers of the autonomic nervous system.
- January 23, 2017
TCGA study identifies genomic features of cervical cancer
TCGA's comprehensive analysis of cervical cancer found genomic alterations that may help target therapies, and revealed a small subset of tumors that were not linked to human papillomavirus (HPV) infection. Photo Credit: The Cancer Genome Atlas et al. Nature. [CC-BY-4.0]
- January 04, 2017
TCGA study of esophageal cancers finds features that aid in their classification
A new study by The Cancer Genome Atlas Research Network found genomic differences between the two most common types of esophageal cancer that help place them in the spectrum of cancers from the stomach to the head and neck. Image Credit: Toshinori Hinoue, Ryo Sakai, Peter W. Laird
- June 10, 2015
Brain Tumor’s Genetic Makeup Critical in Treatment, Research Finds
The New York Times describes the important findings from TCGA's research on lower grade gliomas.
- January 27, 2015
Warning: That Tan Could Be Hazardous
The New York Times reports on TCGA data bolstering the case for the link between melanoma and ultraviolet light exposure.
- October 06, 2014
Cancer Genome Sequencing Will Mean More Targeted Therapies
Forbes interviews Dr. Carolyn Hutter, NHGRI team lead for TCGA, about the influence of cancer genomics on the future of precision medicine.
Histopathological image of cerebral glioblastoma.
View All Images >
The difference between a normal cell and cancer cell and how understanding the changes in DNA that cause cancer can help doctors develop better treatments.
View All Videos >
| From the NIH
View All Audio >